Table 3.
Association of PTENP1 pseudogene methylation with the clinical and pathological characteristics of endometrial cancer patients
| Clinical and pathological characteristics | n | M(U) | M, % | p |
|---|---|---|---|---|
| Mean age (extreme values) | 0.784 | |||
| 55 (48–60) | 27 | 19(8) | 70.37 | |
| 68 (61–76) | 30 | 20(10) | 66.66 | |
| FIGO stage | 1.00 | |||
| I | 46 | 31(15) | 67.39 | |
| II + III | 11 | 8(3) | 72.73 | |
| Invasion into endometrium | 0.359 | |||
| Yes | 17 | 10(7) | 58.82 | |
| No | 40 | 29(11) | 72.50 | |
| Tumor differentiation | 0.774 | |||
| high (G1) | 31 | 21(10) | 67.74 | |
| moderate and low (G2 + G3) | 26 | 19(7) | 73.08 | |
| Bokhman subtype | ||||
| I | 19 | 14(5) | 73.68 | 1.00 |
| II | 11 | 8(3) | 72.73 |
Note. Two-sided Fisher exact test; M – methylated; U – unmethylated.